More about

Vincristine

News
February 23, 2024
2 min watch
Save

VIDEO: Exploring available treatment options in DLBCL

In this video, Tycel Phillips, MD, discusses treatment options available to patients with DLBCL.

News
February 23, 2024
1 min watch
Save

VIDEO: Diagnostic challenges in DLBCL

In this video, Tycel Phillips, MD, discusses challenges in diagnosing DLBCL.

News
September 06, 2023
2 min read
Save

Regimens confer comparable OS among adolescents, young adults with ALL

Pediatric-inspired protocols and hyper-CVAD conferred comparable survival for adolescents and young adults with Philadelphia chromosome-negative acute lymphoblastic leukemia, according to study results.

News
February 01, 2023
1 min read
Save

Two treatment regimens improve quality of life among patients with DLBCL

NEW ORLEANS — Health-related quality of life in patients with diffuse large B-cell lymphoma improved in a comparison of two therapy regimens.

News
May 13, 2021
3 min read
Save

Brentuximab vedotin shows promise in high-risk pediatric Hodgkin lymphoma

The replacement of vincristine with brentuximab vedotin in standard front-line treatment appeared safe and effective among children and adolescents with high-risk classical Hodgkin lymphoma, according to phase 2 study results.

News
December 05, 2019
5 min read
Save

Child presents with bilateral poor vision

A 7-year-old boy presented to a satellite office of the New England Eye Center after referral from a local optometrist for persistently decreased vision despite appropriate spectacle correction for myopia and astigmatism. The optometrist had diagnosed him with refractory amblyopia and referred him for further evaluation given minimal improvement in vision with glasses and a short trial with patching.

News
October 31, 2019
1 min read
Save

Yogurt may lower lung cancer risk, FDA recommends boxed warning on breast implants — top stories in hematology/oncology

Findings that people who ate large amounts of yogurt and dietary fiber had a decreased risk for lung cancer was the top story in hematology/oncology last week.

News
October 23, 2019
6 min read
Save

Vincristine shortage underscores vulnerability of ‘fragile market’ for crucial treatments

A shortage of the chemotherapy drug vincristine, which is essential to the treatment of most pediatric cancers, has left the oncology community struggling to find short-term solutions while recognizing the need for long-term reform.